Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 117

1.

Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease.

Ghosh A, Tyson T, George S, Hildebrandt EN, Steiner JA, Madaj Z, Schulz E, Machiela E, McDonald WG, Escobar Galvis ML, Kordower JH, Van Raamsdonk JM, Colca JR, Brundin P.

Sci Transl Med. 2016 Dec 7;8(368):368ra174.

PMID:
27928028
2.

Neuromodulation Treatments for Geriatric Mood and Cognitive Disorders.

McDonald WM.

Am J Geriatr Psychiatry. 2016 Dec;24(12):1130-1141. doi: 10.1016/j.jagp.2016.08.014. Review.

PMID:
27889282
3.

Use of Orally Disintegrating Olanzapine During Electroconvulsive Therapy for Prevention of Postictal Agitation.

Hermida AP, Janjua AU, Tang Y, Syre SR, Job G, McDonald WM.

J Psychiatr Pract. 2016 Nov;22(6):459-462.

PMID:
27824778
4.

Study design and methodology for a multicentre, randomised controlled trial of transcranial direct current stimulation as a treatment for unipolar and bipolar depression.

Alonzo A, Aaronson S, Bikson M, Husain M, Lisanby S, Martin D, McClintock SM, McDonald WM, O'Reardon J, Esmailpoor Z, Loo C.

Contemp Clin Trials. 2016 Nov;51:65-71. doi: 10.1016/j.cct.2016.10.002.

PMID:
27756567
5.

The FDA and ECT.

McDonald WM, Weiner RD, Fochtmann LJ, McCall WV.

J ECT. 2016 Jun;32(2):75-7. doi: 10.1097/YCT.0000000000000326. No abstract available.

PMID:
27191123
6.

Development of the Comprehensive Cervical Dystonia Rating Scale: Methodology.

Comella CL, Fox SH, Bhatia KP, Perlmutter JS, Jinnah HA, Zurowski M, McDonald WM, Marsh L, Rosen AR, Waliczek T, Wright LJ, Galpern WR, Stebbins GT.

Mov Disord Clin Pract. 2015 Jun;2(2):135-141.

7.

Beyond the Psychiatric Horizon: Preparing Residents for the Twenty-First Century.

Rakofsky JJ, Cotes RO, McDonald WM, Schwartz AC, Rapaport MH.

Acad Psychiatry. 2017 Feb;41(1):125-131. doi: 10.1007/s40596-016-0517-z. No abstract available.

PMID:
26955812
8.

Trajectories of recovery in depressed Parkinson's disease patients treated with paroxetine or venlafaxine.

Broen MP, Leentjens AF, Köhler S, Kuijf ML, McDonald WM, Richard IH.

Parkinsonism Relat Disord. 2016 Feb;23:80-5. doi: 10.1016/j.parkreldis.2015.12.013.

PMID:
26739248
9.

Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.

Newport DJ, Carpenter LL, McDonald WM, Potash JB, Tohen M, Nemeroff CB; APA Council of Research Task Force on Novel Biomarkers and Treatments..

Am J Psychiatry. 2015 Oct;172(10):950-66. doi: 10.1176/appi.ajp.2015.15040465. Review.

PMID:
26423481
10.

Cognitive correlates of hallucinations and delusions in Parkinson's disease.

Factor SA, Scullin MK, Sollinger AB, Land JO, Wood-Siverio C, Zanders L, Freeman A, Bliwise DL, McDonald WM, Goldstein FC.

J Neurol Sci. 2014 Dec 15;347(1-2):316-21. doi: 10.1016/j.jns.2014.10.033.

PMID:
25466695
11.

Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.

Parashos SA, Luo S, Biglan KM, Bodis-Wollner I, He B, Liang GS, Ross GW, Tilley BC, Shulman LM; NET-PD Investigators..

JAMA Neurol. 2014 Jun;71(6):710-6. doi: 10.1001/jamaneurol.2014.391.

12.

Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.

Moonen AJ, Wijers A, Leentjens AF, Christine CW, Factor SA, Juncos J, Lyness JM, Marsh L, Panisset M, Pfeiffer R, Rottenberg D, Serrano Ramos C, Shulman L, Singer C, Slevin J, McDonald W, Auinger P, Richard IH.

Parkinsonism Relat Disord. 2014 Jun;20(6):644-6. doi: 10.1016/j.parkreldis.2014.02.025.

PMID:
24679737
13.

The role of electroconvulsive and neuromodulation therapies in the treatment of geriatric depression.

Riva-Posse P, Hermida AP, McDonald WM.

Psychiatr Clin North Am. 2013 Dec;36(4):607-30. doi: 10.1016/j.psc.2013.08.007. Review.

PMID:
24229660
14.

Psychiatric comorbidities in dystonia: emerging concepts.

Zurowski M, McDonald WM, Fox S, Marsh L.

Mov Disord. 2013 Jun 15;28(7):914-20. doi: 10.1002/mds.25501. Review.

15.

The painfulness of active, but not sham, transcranial magnetic stimulation decreases rapidly over time: results from the double-blind phase of the OPT-TMS Trial.

Borckardt JJ, Nahas ZH, Teal J, Lisanby SH, McDonald WM, Avery D, Durkalski V, Pavlicova M, Long JM, Sackeim HA, George MS.

Brain Stimul. 2013 Nov;6(6):925-8. doi: 10.1016/j.brs.2013.04.009.

16.

Web-based involuntary-commitment educational project for emergency medicine residents: an interdepartmental quality initiative.

Vahabzadeh A, Wittenauer J, McDonald WM.

Acad Psychiatry. 2013 Jan 1;37(1):64-5. doi: 10.1176/appi.ap.12050097. No abstract available.

PMID:
23338880
17.

Physicians' warnings for unfit drivers and risk of road crashes.

Vahabzadeh A, McDonald WM.

N Engl J Med. 2013 Jan 3;368(1):86-7. doi: 10.1056/NEJMc1212928#SA1. No abstract available.

PMID:
23281993
18.

The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?

Hermida AP, McDonald WM, Steenland K, Levey A.

Expert Rev Neurother. 2012 Nov;12(11):1339-50. doi: 10.1586/ern.12.127. Review.

19.

New insights from China on the efficacy of ECT in schizophrenia.

McDonald WM.

J ECT. 2012 Dec;28(4):203-4. doi: 10.1097/YCT.0b013e31826563ef. No abstract available.

PMID:
23164724
20.

Electroconvulsive therapy in China (II): research on the technical parameters and mechanism of action.

Ren YP, Jiang W, Cotes RO, Tang YL, Ma X, McDonald WM.

J ECT. 2012 Dec;28(4):213-8. doi: 10.1097/YCT.0b013e3182617ef9. Review.

PMID:
23041767
Items per page

Supplemental Content

Loading ...
Support Center